Introduction
During normal homeostasis and tissue turnover large numbers of cells undergoing apoptosis are promptly removed and replaced. The removal of apoptotic material plays an important role in the suppression of inflammation and the regulation of immune responses [1] [2] [3] . Apoptotic cells are a rich source of autoantigens 4 , which are involved in the physiologic maintenance of self-tolerance. The uptake and processing of apoptotic cells has been proposed to be a silent process, meaning that release of pro-inflammatory cytokines by phagocytes is prevented [5] [6] [7] [8] . Impaired clearance of apoptotic cells, resulting in an accumulation of late apoptotic and secondary necrotic cells, might provide a danger signal to antigen presenting cells (APCs), thus activating autoreactive T cells, and finally leading to the breakdown of peripheral tolerance 3 .
Accumulating evidence has been provided that defective clearance of apoptotic cells can lead to exacerbation of inflammation and predisposes to the development of autoimmunity, such as in systemic lupus erythematosus (SLE) 9 .
The apoptotic cell clearance machinery includes professional phagocytes, i.e.
immature dendritic cells (DCs) and macrophages (MØ), and non-professional phagocytes, including epithelial cells, fibroblasts and mesangial cells 10 . It has become clear that there are various subsets in both DCs and MØ [11] [12] [13] . Recent in vitro data show that MØ can be polarized into pro-inflammatory (MØ1) and anti-inflammatory cells (MØ2) by granulocyte/macrophage colony-stimulating factors (GM-CSF) and M-CSF (also termed CSF-1), respectively 14, 15 . Classically, GM-CSF and M-CSF are thought to be the primary growth factors for the differentiation of macrophages 16 .
Mice lacking M-CSF develop a general MØ deficiency 17 , whereas GM-CSFknockout mice showed no major deficiency of MØ 18, 19 . In humans, M-CSF, but not GM-CSF, is an ubiquitous cytokine circulating in the human body 14, 20 .
Thus, M-CSF
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The removal of apoptotic cells is an ongoing and constitutive process. Apoptotic cells provide "eat me signals" to phagocytes to promptly and efficiently engulf apoptotic cells during the very early stage of cell death, preventing them to release noxious intracellular contents 21 . Although the silent removal of early apoptotic cells is well appreciated, the immunological mechanisms involved are incompletely defined. There are several checkpoints conceivable which together determine the immunological response towards the clearance of apoptotic cells. First, the process and the stage of cell death and/or the specific death pathways triggered are closely related to the consequence of apoptotic cell clearance 22 . It has been established that late apoptotic or necrotic cells induce phagocyte activation whereas early apoptotic cells do not 23, 24 .
This is most likely due to differential expression of markers of cell death, such as heat shock proteins 25 , HMGB1 26 and uric acid 27 . Second, opsonization of apoptotic cells by components of the innate immune system such as complement factors facilitates and modulates the clearance of apoptotic cells (reviewed in 28 ). Third, the nature of phagocytes that take up apoptotic cells might provide a defined immunological response.
Due to the large heterogeneity of phagocytes, the contribution of different phagocyte subsets in the clearance of apoptotic cells in terms of cytokine signature and the polarization of immune regulation remains largely unknown. In this respect, we hypothesize that under steady-state conditions, the scavenging of apoptotic cells is largely confined to a specialized phagocyte subset with anti-inflammatory properties.
To test this hypothesis, we compared three types of phagocytes, DC, MØ1 and MØ2, with respect to the phagocytosis of apoptotic cells at various stages of cell death. Our 
Materials and Methods

Generation of monocyte-derived DCs, MØ1 and MØ2.
Human mononuclear cells were isolated from buffy-coats obtained from healthy donors using Ficoll-Hypaque (Sigma-Aldrich, St. Louis, MO), followed by anti-CD14 microbeads magnetic cell sorting, according to the manufacturer's instruction (Miltenybiotec/CLB, Amsterdam, the Netherlands). DCs were generated in 6-well culture plates (Costar, Cambridge, MA) in RPMI culture medium (RPMI 1640 containing 10% heat-inactivated FCS, 90 U/ml penicillin and 90 μg/ml streptomycin) (all from Gibco/Life technologies, Breda, the Netherlands) supplemented with 5 ng/ml GM-CSF (Leucomax, Novartis Pharma BV, Arnhem, the Netherlands) and 10 ng/ml IL-4 (PeproTech, Rocky Hill, NJ) for at least 6 days, as previously described 29 .
Two types of macrophages, namely MØ1 and MØ2, were generated in the same RPMI culture medium as DCs but supplemented with 5 ng/ml GM-CSF and 5 ng/ml M-CSF (R&D systems / ITK Diagnostics, Uithoorn, the Netherlands), respectively. In some experiments, MØ2 were generated in the presence of M-CSF and 10 μg/ml neutralizing anti-IL-10-receptor mAb 30 . In all experiments comparing these three types of phagocytes, they were generated in parallel from monocytes of the same donor. Separate unrelated donors were used for each independent experiment.
Analysis of cell surface molecules by flow cytometry.
Cells were harvested and washed in buffer containing 1% BSA, 1% heat-inactivated normal human serum, and 0.02% NaN 3 . The following mAbs were used for flow cytometry analysis to analyze the surface molecules of phagocytes: anti-CD1a (Leu-6),
anti-CD14 (Leu-M3), anti-CD11b/Mac-1 (all from BD Biosciences, San Jose, CA), 
Cytokine detection.
DCs, MØ1 and MØ2 were stimulated with 200 ng/ml lipopolysaccharide (LPS, Salmonella Typhosa, Sigma-Aldrich) for 24 h and supernatants were harvested.
Cytokines were detected in the supernatants using ELISA. The measurements of IL-6
and TNF-α were performed as described before 35 . The analysis of IL-10 was performed according to the manufacturer's instructions (Sanquin Research, Amsterdam, the Netherlands).
Co-culture was performed by incubating DCs, MØ1 and MØ2 with etoposide-induced apoptotic cells at a 1:1 ratio in RPMI culture medium. After 24 h, supernatants were harvested and tested for IL-6, IL-10 and TNF-α production.
Endocytosis and macropinocytosis assays.
Lectin-mediated endocytosis was examined following co-incubation of phagocytes (1×10 5 ) with 100 µg/ml Dextran FITC (Molecular Probes) for 30 or 60 min at 37°C in RPMI culture medium. Control experiments were done at 4°C. Blocking experiments were performed by pre-incubation of phagocytes for 20 min with 100 µg/ml mannan, or 50 mM D-mannose (both from Sigma-Aldrich). Incubation with 50 mM Lmannose (Sigma-Aldrich) or culture medium only was used as a negative control.
Macropinocytosis was measured as the cellular uptake of 100 µg/ml lucifer yellow (LY) dipotassium salt (Molecular Probes) or 0.2 µg/ml BSA FITC (Sigma-Aldrich).
Cells were washed extensively with cold PBS containing 1% FCS and 0.02% NaN 3 .
Before analysis with flow cytometry, the cell surface fluorescence was quenched with trypan blue (Sigma-Aldrich). To quantify the uptake, mean fluorescence intensity (MFI) values obtained at 4°C were subtracted from MFI values obtained at 37°C.
Inhibition of uptake of apoptotic cells
To assess the role of phosphatidylserine (PS) in the uptake of early apoptotic cells by MØ2, early apoptotic cells were pre-incubated with recombinant annexin V (SigmaAldrich) (up to 50 µg/ml) at 4ºC for 20 min to mask PS, before incubation with MØ2.
To assess the role of CD14 in the apoptotic cell clearance, MØ1 and MØ2 were treated with an anti-CD14 blocking mAb (61D3, a kind gift of Dr. C. Gregory, University of Edinburgh, U.K.). MØ were pre-incubated with 61D3 (20 µg/ml) for 20 min at 4ºC before addition of UV-induced early apoptotic cells or etoposide-induced apoptotic cells.
To investigate the role of macropinocytosis in the uptake of apoptotic cells by MØ1
and MØ2, 5-(N, N-Dimethyl)amiloride hydrochloride (DMA, Sigma-Aldrich) was used to inhibit macropinocytosis. MØ1 and MØ2 were pre-incubated with DMA (up to 1 mM) at 37ºC for 20 min before early apoptotic cells or apoptotic blebs were added.
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Statistical analysis.
Statistical analysis was performed by two-way ANOVA, Chi-square or one sample t test using GraphPad Prism (GraphPad software, San Diego, CA). Differences were considered statistically significant when p values were less than 0.05.
Results
Characterization of DCs, MØ1 and MØ2.
Three types of phagocytes were generated from peripheral blood monocytes by different cytokines, i.e. IL-4 and GM-CSF for DCs, GM-CSF for MØ1, and M-CSF for MØ2, respectively. MØ2 were less-adherent cells, with irregular shapes compared with MØ1 (Fig. 1A) . In contrast to DCs, MØ1 and MØ2 shared the typical macrophage phenotype, being positive for CD14, but negative for CD1a and DC-SIGN (Fig. 1B) . Notably, MØ2 expressed higher levels of CD14, but much lower level of mannose receptors (MR) than MØ1. All three cell types showed expression of CD11b.
Uptake of apoptotic cells by DCs, MØ1 and MØ2.
To investigate the phagocytosis of these three phagocyte subsets, apoptosis was induced in Jurkat cells using etoposide for 18 hours at 37°C in serum-free RPMI culture medium, as described before 32 for all three type of phagocytes), but the binding at 4°C was stable (Fig. 2B ).
To confirm and quantify the uptake of apoptotic cells by MØ1 and MØ2, confocal microscopy was used. This analysis clearly showed the presence of CFSE-labeled apoptotic material inside the cells (Fig. 2C) . Quantification of phagocytic index confirmed our FACS data that MØ2 were more potent in the uptake of apoptotic cells than MØ1 (Fig. 2D) . The higher phagocytic index in MØ2 was due to a significantly higher percentage of MØ2 contributing to the uptake as compared to MØ1 (Chisquare test, p<0.0001), whereas the number of apoptotic cells taken up per macrophage between MØ1 and MØ2 were similar (2.33 vs 2.55, respectively). There seems to be a quantitative difference in the measurements by FACS and confocal microscopy. However, these experiments were not performed side-by-side and are therefore dependent on variation between donors. Moreover, for FACS analysis cells were in solution which might affect their phagocytic behavior. It is important to note that for differences between MØ1 and MØ2, cells were in all cases generated in parallel from the same donor.
To determine whether the observed highly phagocytic capacity of MØ2 represent a generalized increase on phagocytosis, uptake of E IgG was investigated. We found that the phagocytic index of MØ2 is 6.84 fold higher than that of MØ1 (mean of 3 independent experiments) (Fig. 2E, F) . This is especially explained by the fact the percentage of MØ2 contributing to the uptake was significantly higher than that of MØ1 (Chi-square test, p<0.0001 for all three independent experiments), whereas the number of erythrocytes taken up per macrophage between MØ1 (1.83 ± 0.17) and MØ2 (2.23 ± 0.72) showed no difference (paired t test, p=0.40). The non-opsonized
were not ingested by MØ1, whereas the uptake by MØ2 was of low efficiency (phagocytic index <0.1, data not shown). Together, these data clearly show that MØ2 have a more generalized higher capacity of phagocytosis than MØ1.
MØ2 retain their anti-inflammatory status after uptake of apoptotic cells.
It has been proposed that clearance of apoptotic material is a non-inflammatory process [1] [2] [3] . Therefore we investigated the functional consequences of uptake of apoptotic cells by MØ1 or MØ2 by measuring the cytokine release in supernatants.
The capacity of cytokine production by the three phagocyte subsets was first investigated using LPS stimulation (Fig. 3A-C) . LPS-stimulated MØ2 produced large amounts of IL-10, but failed to secrete IL-6 and TNF-α. In contrast, MØ1 produced high amounts of IL-6 and TNF-α after LPS stimulation, whereas IL-10 was hardly detectable. DCs derived from the same donor were able to produce IL-10, IL-6 and TNF-α following LPS stimulation.
MØ2 showed intrinsic IL-10 production (Fig. 3A, D) , which was retained after uptake of apoptotic cells (Fig. 3D) , whereas production of IL-6 or TNF-α was not induced (Fig. 3E-F) . Importantly, uptake of apoptotic cells by MØ1 resulted in a downregulation of IL-6 and TNF-α production, but no induction of IL-10 ( Fig. 3D-F) .
Upon exposure to apoptotic cells, DCs did not secrete IL-10, IL-6 or TNF-α.
MØ2 preferentially take up early apoptotic cells.
To assess whether there are differences among these three types of phagocytes in the uptake of apoptotic cells in different stages of cell death, Jurkat cells were exposed to UV light. Four hours after UV irradiation, around 50-70% early apoptotic cells (annexin V + / PI -) were obtained (Fig. 4A) . Thirty hours after UV irradiation, around 70-95% of cells were late apoptotic (PI + ). Necrotic cells generated by heat shock were all PI-positive. Viable cells were used as a negative control. All three types of phagocytes were unable to take up viable cells (Fig. 4B) . Importantly, MØ2 were the only phagocytes that were able to distinguish early apoptotic cells from late apoptotic and necrotic cells. MØ2 have a preferential uptake of early apoptotic cells, compared to late apoptotic or necrotic cells (Fig. 4B) . In contrast, DCs and MØ1 show an equal efficiency in the uptake of early apoptotic, late apoptotic or necrotic cells.
Furthermore, the efficiency of taking up early apoptotic cells by MØ2 is at least 2-fold higher than that by DCs and MØ1 (mean ± SD of phagocytosis of MØ2: MØ1 from 5 independent experiments is: 2.65 ± 0.62, p<0.0001, two-way ANOVA).
It has been show that IL-10-activated MØ have increased phagocytic capacity for the uptake of apoptotic cells 36 . To investigate whether IL-10-producing MØ2 become highly phagocytic to early apoptotic cells as a consequence of the IL-10 environment created by themselves, we generated MØ2 in the presence of neutralizing anti-IL-10-receptor mAb. Although the anti-IL-10-receptor mAb inhibited the endogenous IL-10 production of MØ2 (data not shown), it did not inhibit phagocytosis of early apoptotic cells as compared to MØ2 generated in the absence of anti-IL-10-receptor mAb (Fig.   4C ). We conclude that endogenous IL-10 produced by MØ2 is not involved in driving the development of high capacity for phagocytosis of early apoptotic cells.
Role of PS and CD14 in the uptake of apoptotic cells by MØ1 and MØ2.
A major feature of early apoptosis is the redistribution of PS from the inner layer of the cell membrane to the outside. Therefore we next investigated whether PS is involved in the phagocytosis by MØ2. Pre-incubation of early apoptotic cells with
non-labeled annexin V prevented binding of FITC-labeled annexin V, confirming an
For personal use only. on September 14, 2017. by guest www.bloodjournal.org From effective masking of PS (data not shown), as described before 32, 37 . The uptake of early apoptotic cells by MØ2 was only partially inhibited after PS masking (inhibition was between 6.5% to 23.2% in three independent experiments), and this effect could not be improved by applying a higher concentration of annexin V (Fig. 5A) .
CD14 has been shown to be involved in the recognition of apoptotic cells by MØ 38 .
As a possible explanation for their efficient uptake of apoptotic cells, we noticed that MØ2 express a significantly higher level of CD14 compared to MØ1 (Fig. 1B and Fig.   5B ). Surface expression of CD14 on MØ1 is heterogeneous (Fig. 1B) . Based on the FACS dot-plots, MØ1 were equally divided into two populations: CD14 high and CD14 low (Fig. 5C ). Phagocytosis experiments showed that CD14 high cells were twice as efficient in binding and uptake of apoptotic cells compared to CD14 low cells (Fig.   5C ). Thus we further investigated the role of CD14 in the engulfment of early apoptotic cells by using a blocking antibody against CD14, mAb 61D3 38 . The uptake of early apoptotic cells by both MØ1 and MØ2 was not significantly inhibited by this mAb. We did observe that the binding of early apoptotic cells by MØ2 at 4ºC was inhibited (p<0.001) (Fig. 5D ). Similar data were obtained when apoptosis was induced with either UV or etoposide. Together, these data indicate that CD14 is involved in tethering but not engulfing apoptotic cells.
Uptake of early apoptotic cells by MØ2 is mediated by macropinocytosis.
Phagocytes take up antigens via receptor-mediated endocytosis mostly by C-type lectins, such as mannose receptors (MR), or via macropinocytosis (fluid phase endocytosis) 39, 40 . Therefore, we investigated lectin-mediated endocytosis of soluble antigens using Dextran FITC . Despite the fact that MØ2 showed a significantly lower expression of MR (Fig. 1B and Fig. 6A ), the uptake of Dextran FITC by MØ1 and MØ2
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In contrast, pre-treatment of MØ2 by mannan or D-mannose inhibited the uptake of Dextran FITC only by 50% (Fig. 6C) , suggesting the involvement of lectin-independent mechanisms such as macropinocytosis. Indeed, for the uptake of both BSA FITC and LY, MØ2 were shown to be 2-to 3-fold more efficient compared to MØ1 and DCs (ANOVA, p<0.001) (Fig. 6D, 6E ).
To investigate a possible contribution of macropinocytosis in the uptake of early apoptotic cells by MØ2, DMA, a Na + /H + antiporter blocker, was used to inhibit the fluid phase uptake by macropinocytosis 39 . DMA treatment of MØ2 not only inhibited the uptake of both BSA FITC and LY (Fig. 7A ), but also inhibited the uptake of early apoptotic cells in a dose-dependent fashion (Fig. 7B ), without interfering with the viability of the cells. Similarly, DMA also inhibited the uptake of early apoptotic cells by CD14 high MØ1 (Fig. 7C) .
We next investigated the uptake of microparticles derived from apoptotic cells (apoptotic blebs). MØ2 were able to take up apoptotic blebs twice as efficiently as MØ1 (Fig. 7D) . DMA inhibited the uptake of apoptotic blebs by MØ2 dosedependently (Fig. 7E) , and in concentrations that are lower than needed for the inhibition of uptake of early apoptotic cells.
Discussion
Over the last few years, it has become clear that both DCs and MØ show a large heterogeneity 11, 13 . We hypothesized that distinct phagocyte subsets contribute differentially to the clearance of apoptotic cells. Here we identify that the IL-10-producing MØ2 are potent phagocytes that have the unique capacity to preferentially bind and ingest early apoptotic cells. This macrophage subset has intrinsic antiinflammatory properties, characterized by high IL-10 production in the absence of pro-inflammatory cytokines, such as IL-6 and TNF-α. IL-10 is an important antiinflammatory cytokine, which is able to limit and ultimately terminate inflammatory responses and plays a role in differentiation of regulatory T cells 41 . 
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It has been shown that IL-10-activated MØ obtain enhanced capacity for the uptake of apoptotic cells 36 . However, phagocytosis experiments using MØ2 generated in the presence of neutralizing anti-IL-10-receptor mAb suggested that endogenous IL-10 produced by MØ2 is not involved in driving the development of high capacity for phagocytosis of early apoptotic cells. However, inhibition of endogenous IL-10 production suggested that there is a positive feedback loop of IL-10 production. We should note that the endogenous production of IL-10 we observed was relatively low and was observed only at the end of the 6-7 day culture period. This might explain the suggested discrepancy with the study of Ogden et al. 36 , where higher amounts of IL-10 have been added from the start of the culture and clearly showed effects on the phagocytic capacity. In conclusion, we feel that in our experiments endogenous IL-10 production is not required for the development of cells with a high phagocytic activity.
Both GM-CSF and M-CSF are key growth factors, not only for MØ generation in vitro, but also for MØ differentiation in vivo. Op/op mice lacking M-CSF develop a profound macrophage deficiency, and this could be partially corrected by the implantation of diffusion chambers containing M-CSF-producing cells 17 , confirming that M-CSF is crucial in MØ differentiation. GM-CSF knockout mice did not show major deficiency of MØ, although the MØ are smaller than normal 18, 19 . Under steady-state conditions, M-CSF is the only primary MØ growth factor detectable in peripheral blood 20 . In contrast, GM-CSF is generally viewed as a pro-inflammatory cytokine involved in inflammation and is hardly detectable in circulation 42 . Thus under steady-state conditions, M-CSF could be the default cytokine driving MØ differentiation.
Cell-cell contact with apoptotic cells is sufficient to induce profound inhibition of IL-12 production by activated macrophages, thus preventing them to mount an immune 8 . We show here that, upon uptake of apoptotic cells, MØ2 do not produce pro-inflammatory cytokines such as IL-6 and TNF-α, while their IL-10 production was not inhibited. Importantly, and in line with previous results, uptake of apoptotic cells by MØ1 resulted in a down-regulation of IL-6 and TNF-α production. It has been shown that monocyte-derived MØ differentiated with M-CSF acquire the ability to selectively induce T cell apoptosis in an activation-specific fashion 43 , leading to the speculation that peripheral tolerance can be helped by selectively deleting autoreactive T cells that respond to self-antigen. Therefore, at least two mechanisms might be operational to prevent that uptake of apoptotic cells leads to immune activation.
Recently, CD14 has been reported to play an important role in the recognition of apoptotic cells 38 and was further suggested as a tethering molecule for MØ to recognize apoptotic cells 44 . CD14-/-mice showed a persistence of apoptotic cells, supporting that CD14 plays a broad tethering role in the apoptotic cell clearance in vivo 45 . In our study, CD14 expression is remarkably different between MØ1 (CD14  + ) and MØ2 (CD14 +++ ). Notably, MØ2 have a strong interaction with apoptotic cells already at 4°C. Blocking studies using anti-CD14 antibody showed that CD14 is mainly involved in the surface binding, but hardly in the uptake of apoptotic cells, supporting the notion that CD14 is a tethering molecule rather than an engulfing molecule 38 .
Next to the tethering process, other mechanisms are involved in the engulfment of 
